Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
5
×
biotech
boston blog main
life sciences
national
national blog main
national top stories
novartis
5
×
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
astrazeneca
cancer
covid-19
europe blog main
europe top stories
fda
gilead sciences
graybug vision
pfizer
unity biotechnology
What
bio
roundup
acquisitions
cancer
ceo
daniel
days
gilead
ipo
o’day
sciences
abbvie’s
ahead
announced
august
biggest
biofourmis
biotech
blood
broader
bucks
build
busy
buy
celebrate
chance
collabs
company
company’s
corner
covid
day
deal
debut
decisions
detect
developing
devices
drug
drugs
Language
unset
5
×
Current search:
abbvie
×
unset
×
novartis
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More